This new NCI-led study will help decide if people who have had one or two small benign polyps removed during a routine colonoscopy can wait 10 years for another colonoscopy. The current practice is for these people to have another colonoscopy after 5 and 10 years. Learn more about the FORTE study, including how to join.
A large clinical trial shows that treating precancerous anal lesions in people with HIV reduces anal cancer by more than half. Results from the NCI-funded ANCHOR study were published June 16 in the New England Journal of Medicine.
One dose of the HPV vaccine was highly effective in protecting young women against infection from high-risk HPV types, a clinical trial in Kenya found. Preventing infection with a single dose would make HPV vaccines more accessible worldwide, reducing the global burden of cervical cancer.
Clinical Trials Information for Patients and Caregivers
Federal law requires most health insurance plans to cover routine patient care costs in clinical trials under certain conditions. Learn which types of trials are covered and specific types of costs that are not.
There are ways to learn if your health plan covers routine patient care costs in a clinical trial. This page offers some ideas about who to contact for help, questions to ask, and information to collect and keep if you decide to take part in a trial.
This study will examine the immune responses after COVID vaccination in people with cancer aged 6 months to 37 years. People with cancer often have suppressed or compromised immune systems, but vaccines work by bolstering the immune system to fight infection. Scientists want to see how the immune systems of young people with cancer respond to the COVID vaccine.
In this phase 2 trial, people with thymoma or thymic carcinoma that has come back after or got worse during chemotherapy will be treated with a new kind of drug called PT-112. In lab tests and early trials, this drug killed cancer cells and helped boost the immune response to cancer. Researchers want to see if PT-112 treatment shrinks tumors in these people.
This phase 3 clinical trial will test an internet-based program of coping skills for pain in adults with cancer. People undergoing adjuvant treatment or who have finished cancer treatment but are still experiencing cancer-related pain will be randomly assigned to receive the internet-based program along with standard pain care, or standard pain care alone. Doctors want to see if the internet-based program reduces the pain and the amount of interference in daily life caused by pain compared with the usual pain care alone.
